FTO genotype impacts food intake and corticolimbic activation

Autor: Mary K. Askren, Vidhi Tyagi, Susan J. Melhorn, Mary Rosalynn B. De Leon, Mario Kratz, Rudolph L. Leibel, Tyler A. Bosch, Wendy K. Chung, Thomas J. Grabowski, Mary F. Webb, Ellen A. Schur
Rok vydání: 2018
Předmět:
Blood Glucose
Male
0301 basic medicine
Calorie
Genotyping Techniques
Appetite
Medicine (miscellaneous)
FTO gene
Body Mass Index
0302 clinical medicine
Glucagon-Like Peptide 1
Surveys and Questionnaires
media_common
Meal
Nutrition and Dietetics
Brain
Magnetic Resonance Imaging
Ghrelin
Ventral tegmental area
Original Research Communications
medicine.anatomical_structure
Body Composition
Female
Adult
medicine.medical_specialty
Genotype
media_common.quotation_subject
Alpha-Ketoglutarate-Dependent Dioxygenase FTO
030209 endocrinology & metabolism
Satiation
Polymorphism
Single Nucleotide

Young Adult
03 medical and health sciences
Internal medicine
medicine
Humans
Obesity
Alleles
business.industry
Ventral striatum
medicine.disease
Diet
Cross-Sectional Studies
030104 developmental biology
Endocrinology
Lean body mass
Energy Intake
business
Zdroj: The American Journal of Clinical Nutrition. 107:145-154
ISSN: 0002-9165
DOI: 10.1093/ajcn/nqx029
Popis: BACKGROUND: Variants in the first intron of the fat mass and obesity-associated (FTO) gene increase obesity risk. People with “high-risk” FTO genotypes exhibit preference for high-fat foods, reduced satiety responsiveness, and greater food intake consistent with impaired satiety. OBJECTIVE: We sought central nervous system mechanisms that might underlie impaired satiety perception in people with a higher risk of obesity based on their FTO genotype. DESIGN: We performed a cross-sectional study in a sample that was enriched for obesity and included 20 higher-risk participants with the AA (risk) genotype at the rs9939609 locus of FTO and 94 lower-risk participants with either the AT or TT genotype. We compared subjective appetite, appetite-regulating hormones, caloric intake at a buffet meal, and brain response to visual food cues in an extended satiety network using functional MRI scans acquired before and after a standardized meal. RESULTS: Higher-risk participants reported less subjective fullness (χ(2) = 7.48, P < 0.01), rated calorie-dense food as more appealing (χ(2) = 3.92, P < 0.05), and consumed ∼350 more kilocalories than lower-risk participants (β = 348 kcal, P = 0.03), even after adjusting for fat or lean mass. Premeal, the higher-risk group had greater activation by “fattening” food images (compared with objects) in the medial orbital frontal cortex (β = 11.6; 95% CI: 1.5, 21.7; P < 0.05). Postmeal, the higher-risk subjects had greater activation by fattening (compared with nonfattening) food cues in the ventral tegmental area/substantia nigra (β = 12.8; 95% CI: 2.7, 23.0; P < 0.05), amygdala (β = 10.6; 95% CI: 0.7, 20.5; P < 0.05), and ventral striatum (β = 6.9; 95% CI: 0.2, 13.7; P < 0.05). Moreover, postmeal activation by fattening food cues within the preselected extended satiety network was positively associated with energy intake at the buffet meal (R(2) = 0.29, P = 0.04) and this relation was particularly strong in the dorsal striatum (R(2) = 0.28, P = 0.01), amygdala (R(2) = 0.28, P = 0.03), and ventral tegmental area/substantia nigra (R(2) = 0.27, P = 0.01). CONCLUSION: The findings are consistent with a model in which allelic variants in FTO raise obesity risk through impaired central nervous system satiety processing, thereby increasing food intake. This study is registered at clinicaltrials.gov as NCT02483663.
Databáze: OpenAIRE